BIOMAT Database Logo BIOMAT Database Logo

A case of glucocorticoid-responsive hyperaldosteronism. 1968

K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008661 Metabolism, Inborn Errors Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero. Inborn Errors of Metabolism,Metabolism Errors, Inborn,Error, Inborn Metabolism,Errors Metabolism, Inborn,Errors Metabolisms, Inborn,Errors, Inborn Metabolism,Inborn Errors Metabolism,Inborn Errors Metabolisms,Inborn Metabolism Error,Inborn Metabolism Errors,Metabolism Error, Inborn,Metabolism Inborn Error,Metabolism Inborn Errors,Metabolisms, Inborn Errors
D011276 Pregnanediol An inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.
D011279 Pregnanetriol A metabolite of 17-ALPHA-HYDROXYPROGESTERONE, normally produced in small quantities by the GONADS and the ADRENAL GLANDS, found in URINE. An elevated urinary pregnanetriol is associated with CONGENITAL ADRENAL HYPERPLASIA with a deficiency of STEROID 21-HYDROXYLASE. 5-beta-Pregnane-3,17,20-triol,5beta-Pregnane-3alpha,17alpha,20alpha-triol
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.

Related Publications

K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
Glucocorticoid-suppressible hyperaldosteronism. Ultrastructural observation of a case.
November 1985, Acta pathologica japonica,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
Glucocorticoid-suppressible hyperaldosteronism.
April 1992, Lancet (London, England),
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
[Glucocorticoid suppressible hyperaldosteronism].
January 1987, Zhonghua nei ke za zhi,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma.
April 1988, Endocrinologia japonica,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
Mechanism of glucocorticoid-suppressible hyperaldosteronism.
January 1991, The American journal of medicine,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
[A case of glucocorticoid responsive aldosteronism (author's transl)].
October 1981, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
[Remediable glucocorticoid hyperaldosteronism: molecular diagnosis].
November 1999, Medicina clinica,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
Glucocorticoid-suppressible hyperaldosteronism: an update.
April 1990, The American journal of medicine,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
January 2012, Endocrine journal,
K Miura, and K Yoshinaga, and K Goto, and I Katsushima, and M Maebashi, and H Demura, and M Iino, and R Demura, and T Torikai
Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
December 1989, Endocrinologia japonica,
Copied contents to your clipboard!